LONDON, June 16 /PRNewswire/ -- Responding to reports in the media that Obecalp, a placebo pill for children, is due to be made available on the UK market, the Royal Pharmaceutical Society of Great Britain's (RPSGB) Chief Scientist, Jayne Lawrence said:
"The RPSGB is concerned that this product is due to be made available on the UK market as a placebo pill to give to children.
"As a dietary supplement, the manufacturers have not been required to carry out clinical trials. Further, the use of this drug indicates that symptoms diagnosis and advice have not been sought from a qualified healthcare professional, which runs the risk of misdiagnosis.
"We are also concerned that giving a child the pill reinforces the wrong message - that tablets are the answer for all of life's aches and pains."